On [**2164-9-17**] the patient was continued on total parenteral nutrition and continued to have laboratories checked.
On [**2164-9-19**] the patient was continued on total parenteral nutrition and was on the floor at this time receiving wound care to her stoma site with Nugauze.
Of note, the patient was also on Lovenox for anticoagulation at  this time for atrial fibrillation.
She was also on Digoxin at this time with levels being checked routinely and had been placed on Levofloxacin on [**2164-10-20**] for a urinary tract infection.
In the period leading up to her operation she did of note have other infectious events with 2 central line infections, one in the middle of [**Month (only) 359**] and one at the end of [**Month (only) **] which required transfer into the Intensive Care Unit when she became septic and hypotensive.
However, this was unable to occur due to the septic event that occurred on Sunday, [**2164-12-9**].
The bulk of the management for the interval from [**9-17**] into early [**Month (only) 1096**] was for this complex wound management and optimization of her nutrition prior to the embarkment upon repair of such complicated fistulae and hernias.
She was brought to the operating room on [**2164-12-25**] and underwent an enterectomy with anastomosis with enteroenterostomy, excision of enterotomies, jejunostomy tube placement, adhesiolysis of abdominal adhesions of extensive nature, repair of incisional hernia and implantation of mesh for repair of incisional hernia and myocutaneous fascial flap for repair of incisional hernia.
The patient received 5200 ml of Crystalloid fluid in the operating room and her urine output was 620 ml during the case.
Significant findings during the case were 4 separate enterocutaneous fistulae with resulting 8 separate small bowel openings, a large area of incisional hernia secondary to dehiscence and removal of prosthetic mesh following her previous repair and a total of 24 inches of small intestine that were removed.
The remaining small intestine length was estimated to be greater than 8 feet.
She was an eager participant despite feeling fatigued at times and made significant progress with them.
She had some occasional issues with pain that was treated with Percocet elixir as well as occasional issues with anxiety for which she received lorazepam 0.5 mg IV q 8 hours as needed.
She had no neurologic events during this time.
dose of 50 mg due to the patient's occasional morning episodes of tachycardia where her blood pressure was maintained.
She was fairly diligent in terms of her use of incentive spirometry and breathing exercises and getting herself out of bed and practicing pulmonary toilet.
From a gastrointestinal standpoint she was on lansoprazole oral suspension given once daily for acid suppression.
[**Doctor Last Name **] were no other hematologic abnormalities noted during her hospital stay.
Infectious disease issues were resolved at the time of discharge.
The patient had had several infections during her hospital stay that were treated with various and sundry antibiotics such as linezolid, levofloxacin, fluconazole, Vancomycin, metronidazole, etc.
She was afebrile at the time of discharge and her white counts were within normal limits.
DISCHARGE INSTRUCTIONS:  The patient will be discharged to the rehabilitation facility and to have daily wound care with dressing changes once a day to keep wound clean and dry as needed.
to be made aware if patient having fevers, chills, nausea, vomiting, shortness of breath, chest pain, redness or drainage about the wound or if there are any questions or concerns.
Enterocutaneous fistulae.
Endometrial cancer, status post total abdominal hysterectomy and bilateral salpingo-oophorectomy.
Atrial fibrillation.
Ventral hernia repair.
Partial small bowel resection, take down of enterocutaneous fistulae, closure of abdominal wall and [**First Name8 (NamePattern2) 1661**] [**Last Name (NamePattern1) 1662**] drain placement.
DISCHARGE MEDICATIONS:  Albuterol 0.083% solution, 1 inhalation q 4 - 6 hours as needed for wheezing and shortness of breath.
Ipratropium bromide 0.02% solutions, 1 inhalation q 6 hours as needed for wheezing and shortness of breath.
Patient to have wound care with daily examination and changes of dressing to keep wounds clean and dry as needed.
